Healthsouth 8-K Reaffirms 2015 Guidance

"The Company reiterates as of the date hereof its guidance for 2015, as previously reported in the press release furnished as an exhibit to the Current Report on Form 8-K dated July 29, 2015 and during the Company's earnings conference call held on July 30, 2015. That is, the Company continues to expect to be in the lower end of the following ranges: • Adjusted EBITDA of $670 million to $680 million; and • Earnings per share from continuing operations attributable to HealthSouth of $2.11 to $2.17. The Company will provide the following preliminary observations for the third quarter of 2015: • Inpatient rehabilitation revenue growth is tracking to the higher end of the Company's guidance range, driven primarily by discharge growth. • Home health and hospice continues to experience strong volume growth. The information contained herein is being furnished pursuant to Item 7.01 of Form 8-K, "Regulation FD Disclosure." This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing."